Clinical trial
Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
NCT03500653 is registered in ClinicalTrials.gov with Henit Yanai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
- Lead sponsor
- Henit Yanai
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 9, 2020
- Completion date
- December 31, 2022
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.